In a genetic model of HF related to constitutive activation of AMPK (model of PRKAG2 cardiomyopathy), myocardial glycogen content was increased alongside higher SGLT1 membrane expression [68]. The gene discussed is SLC5A1; the disease is cardiomyopathy.